AUROBINDO PHARMA LTD
Long

a very positive structure with interesting developments

501
the sandoz acquisition, is going to add 50% of the last fy revenue , with balance sheet leveraged to 0.7 de ratio...

disclaimer... not an investing/trading recommendation

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.